ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CLRB Cellectar Biosciences Inc

3.32
0.23 (7.44%)
May 01 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cellectar Biosciences Inc CLRB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.23 7.44% 3.32 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.10 3.08 3.33 3.16 3.09
more quote information »

Recent News

Date Time Source Heading
3/27/202405:40GLOBECellectar Biosciences Reports Financial Results for Year..
3/20/202405:40GLOBECellectar Biosciences to Announce 2023 Year End Earnings..
3/14/202407:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
3/04/202405:40GLOBECellectar Biosciences Reports High Rate of Complete..
2/14/202419:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202405:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
2/02/202405:03EDGAR2Form 8-K - Current report
1/31/202407:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/30/202405:40GLOBECellectar Biosciences Announces Enrollment of the First..
1/25/202415:30EDGAR2Form 8-K - Current report
1/25/202405:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
1/22/202405:40GLOBECellectar Biosciences Reports Complete Central Nervous..
1/16/202405:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
1/12/202405:44GLOBECellectar Biosciences to Host Conference Call with Texas..
1/11/202405:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
1/09/202405:02EDGAR2Form 8-K - Current report
1/08/202405:30GLOBECellectar Biosciences Announces Positive Topline Data..
1/03/202407:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
12/19/202307:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
12/12/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:30GLOBECellectar Biosciences Strengthens Intellectual Property..
12/05/202307:30GLOBECellectar Biosciences to Present at the Targeted..
11/29/202315:31EDGAR2Form 8-K - Current report
11/13/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202306:45EDGAR2Form 8-K - Current report
10/30/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/27/202315:40EDGAR2Form 8-K - Current report
10/25/202315:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/05/202315:45EDGAR2Form S-3 - Registration statement under Securities Act of..
10/02/202315:40EDGAR2Form DEF 14A - Other definitive proxy statements
9/22/202315:40EDGAR2Form PRE 14A - Other preliminary proxy statements
9/08/202316:17EDGAR2Form 8-K - Current report
8/21/202315:30EDGAR2Form 8-K - Current report
8/14/202307:45EDGAR2Form 8-K - Current report
8/14/202307:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/29/202315:31EDGAR2Form 8-K - Current report
6/29/202305:03EDGAR2Form 8-K - Current report
6/28/202317:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock